These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Non-A, non-B hepatitis from intravenous immunoglobulin. Lane RS. Lancet; 1983 Oct 22; 2(8356):974-5. PubMed ID: 6138539 [No Abstract] [Full Text] [Related]
10. Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin. Williams PE, Yap PL, Gillon J, Crawford RJ, Urbaniak SJ, Galea G. Vox Sang; 1989 Oct 22; 57(1):15-8. PubMed ID: 2508325 [Abstract] [Full Text] [Related]
11. The viral safety of intravenous immunoglobulin. Cuthbertson B, Perry RJ, Foster PR, Reid KG, Crawford RJ, Yap PL. J Infect; 1987 Sep 22; 15(2):125-33. PubMed ID: 3117893 [Abstract] [Full Text] [Related]
12. Non-A, non-B hepatitis from intravenous immunoglobulin. Welch AG, Cuthbertson B, McIntosh RV, Foster PR. Lancet; 1983 Nov 19; 2(8360):1198-9. PubMed ID: 6139556 [No Abstract] [Full Text] [Related]
13. Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Berntorp E, Nilsson IM, Ljung R, Widell A. Lancet; 1990 Jun 23; 335(8704):1531-2. PubMed ID: 1972463 [No Abstract] [Full Text] [Related]
14. Non-A, non-B hepatitis associated with a factor IX complex infused during cardiovascular surgery--Arizona. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1986 Jun 20; 35(24):391-4, 399. PubMed ID: 3086697 [No Abstract] [Full Text] [Related]
15. Leads from the MMWR. Non-A, non-B hepatitis associated with a factor IX complex infused during cardiovascular surgery--Arizona. JAMA; 1986 Aug 01; 256(5):573-4. PubMed ID: 3088293 [No Abstract] [Full Text] [Related]
16. Transmission of non-A, non-B hepatitis by pH4-treated immunoglobulin. Morgenthaler JJ, Heiniger HJ. Vox Sang; 1990 Aug 01; 58(4):309-10. PubMed ID: 2119088 [No Abstract] [Full Text] [Related]
17. [Plasma concentrates of factor VIII. Where are we?]. Vicente V. Sangre (Barc); 1989 Feb 01; 34(1):1-3. PubMed ID: 2496481 [No Abstract] [Full Text] [Related]
18. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission. Berger A, Doerr HW, Scharrer I, Weber B. J Med Virol; 1997 Sep 01; 53(1):25-30. PubMed ID: 9298728 [Abstract] [Full Text] [Related]
19. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Björkander J, Cunningham-Rundles C, Lundin P, Olsson R, Söderström R, Hanson LA. Am J Med; 1988 Jan 01; 84(1):107-11. PubMed ID: 3122562 [Abstract] [Full Text] [Related]